Scientific article
English

Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions

Published in

AIDS, vol. 18, no. 14, p. 1951-1953

Publication date

2004

Abstract

In HIV-1-infected patients with long-term undetectable viraemia on highly active antiretroviral treatment (HAART), we found that pre-HAART plasma viraemia and the baseline proviral DNA level were significantly associated with the viraemia setpoint during scheduled treatment interruptions. In long-term treated patients, pre-HAART viraemia may not be available, and in these circumstances proviral DNA, measured at the time of scheduled treatment interruption, can help to identify patients likely to reach a low viraemia setpoint after treatment interruption.

Keywords

  • Antiretroviral Therapy, Highly Active
  • Cohort Studies
  • DNA, Viral
  • HIV Infections/drug therapy/ genetics/virology
  • HIV-1/ genetics
  • Humans
  • Multivariate Analysis
  • Mutation/genetics
  • RNA, Viral/genetics
  • Viremia/genetics/virology

Citation (ISO format)

YERLY FERRILLO, Sabine et al. Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions. In: AIDS, 2004, vol. 18, n° 14, p. 1951–1953. doi: 10.1097/00002030-200409240-00011

Main files (1)

Article

Identifiers

Journal ISSN

0269-9370
644views
0downloads

Technical informations

Creation

21/06/2010 10:27:11

First validation

21/06/2010 10:27:11

Update

14/03/2023 15:46:15

Status update

14/03/2023 15:46:15

Last indexation

29/10/2024 15:22:00
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated